InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Gunderson Thomas James. Director active across 2 companies, notably Merit Medical Systems INC. Aggregated, 10 filings have been published. Activity tracked since 17 June 2021. The latest transaction was filed on 22 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Gunderson Thomas James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
2,134 股0Common StockSEC:0000950170-25-077216:0
2,152 股0Common Stock, No Par ValueSEC:0001415889-25-013724:0
25,000 股@ US$50.5060.5% 占其流量Common Stock, No Par ValueSEC:0001415889-25-006302:0
732 股0Common StockSEC:0000950170-24-065399:0
2,431 股0Common Stock, No Par ValueSEC:0001415889-24-013813:0
25,000 股@ US$34.4039.5% 占其流量Common Stock, No Par ValueSEC:0001415889-24-006503:0
1,193 股0Common StockSEC:0000950170-23-024880:0
2,262 股0Common Stock, No Par ValueSEC:0001415889-23-008481:0
3,050 股0Common Stock, No Par ValueSEC:0001415889-22-005730:0
2,914 股0Common Stock, No Par ValueSEC:0001415889-21-003135:0
10 条申报中的 10 条
About Gunderson Thomas James
Gunderson Thomas James is a director at Merit Medical Systems INC and at TransMedics Group, Inc. He has 10 filings in total, and across the 10 most recent filings covered, the modal transaction nature is Attribution, with a period from 2021-06-21 to 2025-05-23; both buy and sell amounts are 0.
